Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban.
John Stogner, David N Khey, O Hayden Griffin, Bryan Lee Miller, John H Boman
The International journal on drug policy November 1, 2012 DOI: 10.1016/j.drugpo.2012.03.001 via PubMed
Summary
AI-generated from the abstractAfter a well-publicized suicide in 2006 and reports that Salvia divinorum was used as a 'legal high' and cannabis substitute, Florida classified the plant and its active ingredient, salvinorin A, as Schedule I substances on July 1, 2008. Three self-report studies collected from young adults before and after the policy's implementation, along with interviews of law enforcement personnel, examined the policy's relationship with usage rates. Lifetime prevalence of salvia use was largely unchanged, but rates of past year and past month use in Florida were significantly lower following the scheduling. Perceptions of peer use increased markedly, while law enforcement and laboratories rarely encountered salvia possession cases.
Study at a glance
| Characteristics | Mixed methods: three self-report surveys and qualitative interviews Peer reviewed |
|---|---|
| Population | Young adults in Florida and law enforcement personnel from the state's most populated areas |
| Duration | Before and after July 1, 2008 |
| Topics | Salvia divinorum |
| Keywords | Drug policy Substance regulation Drug legislation Prohibition Legal ban |
| Citations | 31 |
| Key finding | Classification of Salvia divinorum as a Schedule I drug in Florida was followed by a substantial reduction in past year and past month recreational use, though lifetime prevalence was largely unchanged. |
Abstract
A plant with dissociative and psychoactive properties began to attract the attention of the media and United States policymakers following a well-publicized suicide in 2006 and reports that the plant served as a 'legal high' and substitute for cannabis. As a result, Salvia divinorum and its active ingredient, salvinorin A, were classified as Schedule I substances by the Florida Legislature on July 1, 2008. As of yet, no research has explored the efficacy of this policy or similar policies in other jurisdictions. Three self-report studies collected from young adults both prior to and following the policy's implementation are employed to investigate the potential relationship between the policy and usage rates. In addition, law enforcement personnel from the state's most populated areas were interviewed to determine the extent to which they were encountering salvia in their work. It was indicated that less than two-thirds of those surveyed were aware of the drug's legal status. Lifetime prevalence of salvia use was largely unchanged. However, the rates of self-reported past year and past month use in Florida were significantly lower following the scheduling. Though use of Salvia divinorum appears to have decreased, perceptions of peer use increased markedly. Law enforcement officers and laboratories reported rarely, if ever, dealing with cases of salvia possession. Data suggests the classification of Salvia divinorum as a Schedule I drug was followed by a substantial reduction in recreational use. We caution that other factors may have influenced use, that the efficacy of scheduling novel substances is likely to vary by drug type, that such a reduction in reported use may only exist transiently until a sophisticated illicit market develops to replace the legitimate one, and that a state's success in regulating salvia may be related to their regulation of and enforcement of other drug prohibitions.